CAICaris Life Sciences Inc.

Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing PR Newswire IRVING, Texas, July 14, 2026 IRVING, Texas, July 14, 2026 /PRNewswire/ -- Caris Life...

Caris Life Sciences Launches Caris Detect, the World's Most Sensitive and Comprehensive Multi-Cancer Early Detection Blood Test Caris Life Sciences Launches Caris Detect, the World's Most Sensitive and Comprehensive Multi-Cancer Early Detection Blood Test PR Newswire IRVING, Texas, July 1, 2026...

Is Caris Life Sciences, Inc. (CAI) Stock Positioned for Growth With AI-Driven Precision Medicine Expansion...

Caris Life Sciences Announces Dual Listing on NYSE Texas Caris Life Sciences Announces Dual Listing on NYSE Texas PR Newswire IRVING, Texas, June 16, 2026 IRVING, Texas, June 16, 2026 /PRNewswire/ -- Caris Life Sciences (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and...

(RTTNews) - Caris Life Sciences (CAI), an AI TechBio company, Monday announced that it has been authorized to repurchase up to $100 million of the company's outstanding common stock...

Caris Life Sciences Announces Share Repurchase Program Caris Life Sciences Announces Share Repurchase Program PR Newswire IRVING, Texas, June 8, 2026 IRVING, Texas, June 8, 2026 /PRNewswire/ -- Caris Life Sciences (Nasdaq: CAI) ("Caris" or the "Company"), a leading next-generation AI TechBio...

Caris Life Sciences Launches Behind the Diagnosis Campaign Spotlighting Patient Lives Transformed by Caris' Comprehensive Genomic Testing Caris Life Sciences Launches Behind the Diagnosis Campaign Spotlighting Patient Lives Transformed by Caris' Comprehensive Genomic Testing PR Newswire IRVING...

Caris Life Sciences Publishes Study on the Caris Lookback Program Demonstrating the Ongoing Clinical Value of Comprehensive Testing with Caris MI Cancer Seek Caris Life Sciences Publishes Study on the Caris Lookback Program Demonstrating the Ongoing Clinical Value of Comprehensive Testing with...

Caris Life Sciences Publishes Study Showing Whole Exome Measurement of Tumor Mutational Burden Results in Increased Overall Survival Compared to Estimates from Targeted Gene Panels Caris Life...